Saturday, November 26, 2022
Google search engine
HomeMarketStocksAurobindo Pharma shares tumble nearly 7% in early trade, hit 52-week low...

Aurobindo Pharma shares tumble nearly 7% in early trade, hit 52-week low after Q2 earnings


Shares of on Monday fell almost 7 per cent in early trade after the corporate reported a 41 per cent decline in its consolidated web revenue for the second quarter ended September 30, 2022. The corporate’s shares plunged 6.52 per cent to its 52-week low of Rs 457.20 on the BSE after a weak starting.

On the NSE, it declined 6.60 per cent to its 52-week low of Rs 457.

Later, it recovered many of the early misplaced floor and traded almost 2 per cent decrease.

Aurobindo Pharma on Saturday reported a 41 per cent decline in its consolidated web revenue at Rs 409 crore for the second quarter ended September 30, 2022.

The Hyderabad-based drug agency had posted a web revenue of Rs 697 crore within the July-September interval of final fiscal.

Income from operations additionally declined to Rs 5,739 crore within the September quarter as towards Rs 5,942 crore within the year-ago interval.

Aurobindo Pharma Vice-Chairman and Managing Director Ok Nithyananda Reddy stated the corporate’s second quarter efficiency was subdued, primarily as a consequence of macro-environment elements and better aggressive depth for some merchandise within the US.

“Nevertheless, we’re assured that our sturdy pipeline of recent merchandise will present impetus to the longer term progress trajectory,” he added.



Source link

RELATED ARTICLES
- Advertisment -
Google search engine

Most Popular

Recent Comments